cdn mobile

7 in Danao City, Alegria test positive for drug use

By: Morexette B. Erram December 08,2017 - 10:35 PM

CPADAO personnel collect urine samples from employees of the Cebu provincial government during a mandatory drug testing held at the Capitol Social Hall on October 9, 2017.
/CDN file

SEVEN government employees tested positive for drugs use during the mandatory drug testing organized by the Cebu Provincial Anti-Drug Abuse Office (CPADAO) from December 1 to 6.

Six of the suspected drug users were from Danao City in northern Cebu while the other one was from Alegria town in the midwestern part of the province.

“(But) we will have to wait for the (outcome of the) confirmatory (testing first) to officially conclude everything else,” said CPADAO head Ivy Durano-Meca.

A total of 843 government personnel from Danao City and the towns of Consolacion, Alegria and Aloguinsan were subject of their mandatory drug testing.

Meca said for now, they still cannot divulge the name of the seven employees because of the need to subject their urine samples to confirmatory testing.

CPADAO, Meca said, will continue to implement mandatory drug testing on employees of other LGU offices in Cebu until December 27 in compliance with Civil Service Commission Resolution No. 1700653 issued in March 2017.

Anyone who will refuse to cooperate and comply with the CSC order, without any valid reason, may face administrative sanctions that would include their suspension from service.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Alegria, drug use, positive, test
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.